Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 12, 2011
Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targetingTomáš Etrych, Jiří Strohalm, Petr Chytil, et al.Nanoscale|July 22, 2017
A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imagingEva Koziolová, Shreya Goel, Petr Chytil, et al.Molecular Cancer Therapeutics|March 5, 2016
Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy ResistanceAnne-Kathrin Heinrich, Henrike Lucas, Lucie Schindler, et al.Acta Biomaterialia|February 15, 2020
Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerizationEva Randárová, Hideaki Nakamura, Rayhanul Islam, et al.International Journal of Pharmaceutics|November 15, 2017
HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release studyWaliul Islam, Jun Fang, Tomas Etrych, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2005
Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunityTomas Mrkvan, Milada Sirova, Tomas Etrych, et al.Bioconjugate Chemistry|April 4, 2007
The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell lineLubomír Kovár, Jirí Strohalm, Petr Chytil, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 22, 2017
Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugateTomáš Etrych, Kenji Tsukigawa, Hideaki Nakamura, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2012
Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyesterEliézer Jäger, Alessandro Jäger, Petr Chytil, et al.Pharmaceutics|February 2, 2021
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for OncotherapyMarina R Tavares, Klára Hrabánková, Rafał Konefał, et al.Pageof 6